Moors & Cabot’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $377K | Sell |
718
-127
| -15% | -$66.7K | 0.02% | 583 |
|
|
2025
Q1 | $536K | Buy |
845
+60
| +8% | +$38.1K | 0.03% | 469 |
|
|
2024
Q4 | $559K | Sell |
785
-12
| -2% | -$8.55K | 0.03% | 469 |
|
|
2024
Q3 | $838K | Sell |
797
-19
| -2% | -$20K | 0.04% | 380 |
|
|
2024
Q2 | $858K | Sell |
816
-50
| -6% | -$52.6K | 0.05% | 340 |
|
|
2024
Q1 | $834K | Buy |
866
+25
| +3% | +$24.1K | 0.05% | 349 |
|
|
2023
Q4 | $739K | Buy |
841
+2
| +0.2% | +$1.76K | 0.05% | 340 |
|
|
2023
Q3 | $690K | Buy |
839
+43
| +5% | +$35.4K | 0.05% | 346 |
|
|
2023
Q2 | $572K | Buy |
796
+2
| +0.3% | +$1.44K | 0.04% | 406 |
|
|
2023
Q1 | $652K | Buy |
794
+7
| +0.9% | +$5.75K | 0.04% | 356 |
|
|
2022
Q4 | $568K | Sell |
787
-9
| -1% | -$6.49K | 0.04% | 382 |
|
|
2022
Q3 | $548K | Sell |
796
-65
| -8% | -$44.7K | 0.04% | 370 |
|
|
2022
Q2 | $509K | Sell |
861
-286
| -25% | -$169K | 0.04% | 406 |
|
|
2022
Q1 | $801K | Sell |
1,147
-40
| -3% | -$27.9K | 0.05% | 344 |
|
|
2021
Q4 | $750K | Sell |
1,187
-168
| -12% | -$106K | 0.05% | 356 |
|
|
2021
Q3 | $818K | Buy |
1,355
+93
| +7% | +$56.1K | 0.05% | 319 |
|
|
2021
Q2 | $705K | Buy |
1,262
+13
| +1% | +$7.26K | 0.05% | 335 |
|
|
2021
Q1 | $585K | Buy |
1,249
+440
| +54% | +$206K | 0.04% | 354 |
|
|
2020
Q4 | $384K | Buy |
809
+29
| +4% | +$13.8K | 0.03% | 454 |
|
|
2020
Q3 | $437K | Buy |
780
+86
| +12% | +$48.2K | 0.04% | 361 |
|
|
2020
Q2 | $433K | Buy |
694
+150
| +28% | +$93.6K | 0.05% | 349 |
|
|
2020
Q1 | $264K | Buy |
+544
| New | +$264K | 0.04% | 416 |
|
|
2018
Q1 | – | Sell |
-600
| Closed | -$227K | – | 601 |
|
|
2017
Q4 | $227K | Buy |
600
+115
| +24% | +$43.5K | 0.03% | 483 |
|
|
2017
Q3 | $217K | Buy |
+485
| New | +$217K | 0.03% | 478 |
|
|
2016
Q2 | – | Sell |
-1,935
| Closed | -$711K | – | 535 |
|
|
2016
Q1 | $711K | Sell |
1,935
-91
| -4% | -$33.4K | 0.13% | 203 |
|
|
2015
Q4 | $1.09M | Sell |
2,026
-558
| -22% | -$300K | 0.2% | 139 |
|
|
2015
Q3 | $1.21M | Buy |
2,584
+178
| +7% | +$83.6K | 0.22% | 119 |
|
|
2015
Q2 | $1.23M | Buy |
2,406
+41
| +2% | +$21K | 0.2% | 124 |
|
|
2015
Q1 | $1.08M | Buy |
2,365
+370
| +19% | +$169K | 0.18% | 137 |
|
|
2014
Q4 | $815K | Sell |
1,995
-25
| -1% | -$10.2K | 0.14% | 172 |
|
|
2014
Q3 | $730K | Sell |
2,020
-100
| -5% | -$36.1K | 0.12% | 186 |
|
|
2014
Q2 | $595K | Buy |
+2,120
| New | +$595K | 0.1% | 230 |
|